View Filter All NewsPress Release Years All Years202120202019201820172016201520142013201220112010 Apply Press Release | July 19, 2021 Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute Pain READ MORE Press Release | July 16, 2021 Vertex to Announce Second-Quarter 2021 Financial Results on July 29 READ MORE Press Release | June 28, 2021 Vertex Announces National Reimbursement Agreement in France for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) and SYMKEVI® (tezacaftor/ivacaftor) for Eligible Cystic Fibrosis Patients READ MORE Press Release | June 25, 2021 Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis READ MORE Pagination First page First Previous page Previous Page 2 Current page 3 Page 4 Next page Next
